Please assess the completion status of the following clinical trial:

Trial Title: Sentinel Node Biopsy and Axillary Sampling in Operable Breast Cancer

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Clinically node negative operable breast cancer~* No prior incision or excision biopsy~Exclusion Criteria:~* Palpable axillary lymph nodes~* Contraindications for injecting radiocolloid

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Radio guided Sentinle node biopsy (Type: EXPERIMENTAL): The radiolabeled Tc-99 colloid or phytate (500 Mbq) will be injected into the primary tumor 2 hours before surgery. A localized scintiscan will then be performed to confirm the radiolabeling of the sentinel node before surgery and for documentation. Isosulphan blue dye will be injected subdermal (0.5ml) over the tumor and intraparenchymal (3-4ml) towards the axilla 10-15mins before incision.

Based on this trial design, predict the completion outcome and termination type (if applicable).